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Abstract
Background: Distal interactions between discrete elements of an enzyme are critical for communication and ultimately for
regulation. However, identifying the components of such interactions has remained elusive due to the delicate nature of
these contacts. Protein kinases are a prime example of an enzyme with multiple regulatory sites that are spatially separate,
yet communicate extensively for tight regulation of activity. Kinase misregulation has been directly linked to a variety of
cancers, underscoring the necessity for understanding intramolecular kinase regulation.
Methodology/Principal Findings: A genetic screen was developed to identify suppressor mutations that restored catalytic
activity in vivo from two kinase-dead Protein Kinase A mutants in S. cerevisiae. The residues defined by the suppressors
provide new insights into kinase regulation. Many of the acquired mutations were distal to the nucleotide binding pocket,
highlighting the relationship of spatially dispersed residues in regulation.
Conclusions/Significance: The suppressor residues provide new insights into kinase regulation, including allosteric effects
on catalytic elements and altered protein-protein interactions. The suppressor mutations identified in this study also share
overlap with mutations identified from an identical screen in the yeast PKA homolog Tpk2, demonstrating functional
conservation for some residues. Some mutations were independently isolated several times at the same sites. These sites
are in agreement with sites previously identified from multiple cancer data sets as areas where acquired somatic mutations
led to cancer progression and drug resistance. This method provides a valuable tool for identifying residues involved in
kinase activity and for studying kinase misregulation in disease states.
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Introduction
Protein kinases comprise one of the largest gene families and are
responsible for regulating cellular processes throughout all stages
of growth and development, including gene transcription [1],
metabolism [2], cell cycle regulation [3] and apoptosis [4]. Critical
regulatory roles performed by kinases are underscored by the
occurrence of numerous cancer phenotypes when kinase activity is
altered or misregulated [5].
The kinase superfamily shares a conserved core that contains
several invariant amino acids that contribute to activity [6]. Of the
kinase superfamily, Protein Kinase A (PKA) is perhaps the best
characterized. The tetrameric holoenzyme of PKA is composed of
two catalytic subunits that possess kinase activity, and two
regulatory subunits that are responsive to cAMP [7,8]. The kinase
domain is composed of a small lobe and a large lobe. The active
site cleft resides between the lobes and is lined with multiple
conserved residues that directly interact with the nucleotide upon
binding (Figure 1). The ATP binding pocket is largely preformed
but undergoes small structural rearrangements during nucleotide
binding, whereas the active site cleft is dynamic and undergoes
large structural changes to allow for nucleotide binding and
catalysis [9]. In order to achieve tightly regulated catalytic activity,
distal regions of the kinase must allosterically communicate with
one another in order to synchronize structural changes [10–12].
Identifying distal components involved in kinase activity has
remained elusive as a consequence of small structural changes and
weak residue interactions. In order to expose these modulators
throughout conserved and non-conserved elements of a kinase, a
structurally non-biased approach was utilized. A genetic screen
was developed to identify suppressor mutations that could restore
catalytic activity from a kinase-dead mutant of PKA. Mutations
were introduced to generate suppressor libraries, and libraries
were screened in an S. cerevisiae strain devoid of native PKA
expression. Since PKA activity is essential for survival, a viability
screen was used to identify mutations that could suppress a
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unidentified residues that are critical for PKA activity. In this
report, we identify suppressor mutations that were isolated from
two discrete genetic backgrounds. The mutations identified in this
study were previously unknown modulators of kinase activity and
point to multiple modes for achieving suppression. This genetic
screen may be applied as a tool to investigate the relationship
between kinase disregulation and various disease states.
Results
The prkaca-L173A and prkaca-F327A alleles cannot
support essential PKA function
As a basis for the genetic screen, we sought to identify
nucleotide binding pocket mutations that would render the kinase
catalytically inactive in vivo. Several key residues within the
nucleotide binding pocket that interact with the nucleotide base
were mutated in the murine isoform of PKA (L49A, V57A,
L104A, M120A, Y122A, L173A, T183A and F327A) [9]. The
mutants were characterized in vivo using the model organism S.
cerevisiae as it affords a genetic background that can be readily
manipulated. Since PKA activity is essential for survival in yeast
[13], a synthetically lethal strain was created by deleting all three
genes encoding PKA (TPK1, TPK2, and TPK3). Plasmid shuffling
revealed that viability could be fully maintained in this strain at
both permissive and elevated temperatures by expressing the
murine isoform of PKA (Figure 2) as previously demonstrated
[14]. In order to identify single mutations that could render PKA
inactive, each site was individually mutated and transformed in the
tpk null strain to evaluate kinase function. The tpk null strain was
initially maintained by expression of wild-type TPK1 from a
URA3-marked plasmid since it has the highest degree of sequence
identity to the murine PKA homolog. Wild-type and mutant PKA
proteins were expressed using the endogenous TPK1 promoter in
LEU2-marked plasmids. Each PKA mutant was subsequently
tested using standard ‘‘plasmid shuffle’’ assays to determine
whether essential PKA function was present in the absence of
TPK1 expression [15].
Growth resulting from co-expression of wild-type and mutant
plasmids (Leu- Ura-) was compared to that of the mutant plasmid
alone (5-fluoroorotic acid, 5-FOA) (Figure 2). When co-expressed
with wild-type Tpk1, most PKA mutants grew comparably to the
wild-type at both permissive (25uC) and elevated temperatures
(34uC). However, a significant growth defect was observed for two
mutants: prkaca-L173A and prkaca-F327A. At both temperatures, the
prkaca-F327A mutant was completely non-viable and had very low
steady-state protein expression (Figure 3A). The prkaca-L173A mutant
demonstrated very weak growth only at the highest concentration.
Both mutants demonstrated significantly reduced catalytic activity in
vitro (Figure 3B). Previous crystallographic analysis reveals that of the
eight residues tested, four residues retain their structural positions
(L49, L104, Y122 and T183) whereas the other four (V57, M120,
L173, and F327) undergo structural changes during nucleotide
binding [16]. The dramatic inability of the prkaca-L173A and prkaca-
F327A mutants to maintain viability in the tpk null strain may indicate
that residues that undergo structural rearrangement may play a more
significant role in regulating nucleotide binding for PKA activity.
Intragenic suppression restores catalytic activity to
prkaca mutants
Using the nonviable prkaca site-directed mutants identified
above, a genetic approach was employed to identify suppressor
mutations that could overcome the non-viable phenotype. The
prkaca-L173A and prkaca-F327A mutants were both selected for
suppressor screening since they provide two unique backgrounds:
L173A lies within the conserved kinase core while F327A lies
within the non-conserved C-terminal tail. Plasmid libraries were
constructed after random mutagenesis of the prkaca-L173A and
prkaca-F327A mutant alleles. These were transformed and screened
for restoration of viability to the tpk null strain using standard
plasmid shuffling. Mutation rates of libraries varied from
approximately 1–20 mutations per 1000 base pairs. Approximate-
ly 25,000 transformants were screened for each allele, and
suppressors were sequenced to identify the acquired mutations.
The suppressors were isolated from each background separately.
Figure 1. Residues highlighted to interact with the nucleotide base in PKA. When PKA is in an ATP-bound state, the small lobe (gray) and
glycine-rich loop move toward the large lobe (sand) to enclose the nucleotide-binding pocket around ATP. A, A global view of PKA in a nucleotide-
bound state. Eight residues have been identified to interact with the nucleotide base: Leu 49, Val 57, Val 104, Met 120, Tyr 122, Leu 173, Thr 183, and
Phe 327 (highlighted yellow). The bound nucleotide is represented as a ball-and-stick figure. The C-terminal tail is colored red, and PKI is colored
magenta. B, Zoomed view into the nucleotide binding pocket. The nucleotide binding pocket is largely preformed with the exception of Val 57, Met
120, Leu 173, and Phe 327 which undergo structural changes upon nucleotide binding. Structure adapted from PDB accession number 1ATP and
modeled using Pymol.
doi:10.1371/journal.pone.0004746.g001
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restore viability to the tpk null strain and were more readily
identified from the prkaca-F327A background than from the prkaca-
L173A background (Tables 1 and 2). Additionally, suppressors
from the pkraca-L173A background required at least two additional
amino acid changes in order to suppress the L173A mutation. Due
to the variance noted between the two discrete genetic
backgrounds during screening, it appears that the modes of
suppression are dependent upon the effects caused by the initial
mutation.
Suppression of the prkaca-L173A mutant
The prkaca-L173A suppressors were first investigated (Figure 4).
The original L173A mutation is buried within the nucleotide
binding pocket of PKA and directly interacts with the nucleotide
base. Notably, some suppressors were independently isolated
several times. Of these, the most commonly isolated suppressor
was one that had acquired mutations at sites M58V and R190C.
Both residue sites are conserved among the PKA family. Met58 is
positioned within the b-sheets of the small lobe and is partially
buried between the small lobe and the C-terminal tail in the
Figure 2. prkaca-L173A and prkaca-F327A cannot support viability in a tpk null strain. Point mutations were introduced at the nucleotide
binding sites indicated in Figure 1B. Coexpression of wild-type and mutant alleles of PKA is demonstrated on Leu-Ura- selection plates. Expression of
the mutants alone is shown on 5-FOA plates. All mutants tested, except prkaca-L173A and prkaca-F327A, were viable at permissive and elevated
temperatures.
doi:10.1371/journal.pone.0004746.g002
Figure 3. The L173A mutant protein is stably expressed but inactive, whereas the F327A mutant has lowered protein expression. A,
Protein expression of each PKA mutant were measured. Of the two mutants that could not complement synthetic lethality in the tpk null strain,
F327A also demonstrated very low protein expression. B, The catalytic activity of each PKA mutant was determined. Both L173A and F327A mutants
had nearly undetectable catalytic activity.
doi:10.1371/journal.pone.0004746.g003
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away from the nucleotide binding pocket near the hinge region
flanking the magnesium-positioning DFG loop. Both residues are
members of an intramolecular interaction network that provides
crosstalk between the hydrophobic lining and the gly-rich and
DFG loops, respectively, of AGC kinases [10]. The high frequency
of isolating this suppressor pair may be due to the simultaneous
effects on multiple known regulatory components of PKA.
Another commonly isolated suppressor from the prkaca-L173A
background acquired a pair of mutations: K28N and E311V.
Interestingly, both residues reside outside of the conserved kinase
core. Lys28 is a solvent-exposed residue in the non-conserved A-
helix of the small lobe. The A-helix regulates kinase activity by
acting as a communication bridge between the small and large
lobes, and also partially anchors the C-helix for nucleotide
positioning. Glu311 is positioned in the C-terminal tail and acts
to help anchor the tail to the large lobe as it undergoes structural
rearrangement upon nucleotide binding to act as a regulator for
access to the active site. Kinase activity may have been restored to
the prkaca-L173A background by coupling effects stemming from
non-conserved elements to alter the activity of the conserved
kinase core.
Suppression of the prkaca-F327A mutant
In order to determine how suppression could be achieved from a
key catalytic residue outside of the conserved kinase core,
suppression of the prkaca-F327A mutant was subsequently exam-
ined. The prkaca-F327A background demonstrates the significance
of a non-conservedelement on kinaseactivity. The F327A mutation
may prevent the C-terminal tailfromfully undergoing the structural
transition after a nucleotide is bound, deeming it both inactive and
structurally unstable (Figure 3). Viable suppressors were isolated
from the prkaca-F327A background (Table 2 and Figure 5). Of note,
suppressors were isolated at a much higher rate as compared to the
prkaca-L173A background and could be isolated from libraries with
low mutation rates.
As seen in the prkaca-L173A background, some suppressors were
identified multiple times. The most frequently isolated mutation
occurred at Leu40. Leu40 is part of the conserved kinase core and
is the first residue of b-strand 1 in the small lobe. This conserved
residue also belongs to an interaction network connecting the
hydrophobic lining of AGC kinases with the glycine-rich loop [10].
The acquired L40S/P mutation likely augments propagated
signaling from the hydrophobic lining of the catalytic domain to
the glycine-rich loop.
Another frequently isolated suppressor was Q149H. This site is
located on the E-helix of the large lobe and interacts with the
proximal end of the C-terminal tail. In a nucleotide-bound state,
Gln149 becomes completely buried by the C-terminal tail. The
Q149H suppressor may promote packing interactions within the
large lobe to support anchoring of the C-terminal tail as it
undergoes the structural transition during nucleotide binding.
Additionally, Q149 is involved in allosteric regulation of the DFG
loop during transitions between active and inactive states [12].
The compensatory Q149H mutation may ease the allosteric
regulation to allow for suppression of the original F327A mutation.
Discussion
Many of the acquired suppressor mutations would not have
necessarily been predicted to significantly impact kinase activity.
As such, it was not obvious in many cases how suppression was
achieved. Of note, many suppressor mutations are structurally
distal to the original L173A mutation. All of the prkaca-L173A
Table 1. Suppressor mutations identified from the prkaca-
L173A background.
Suppressor Changes in Suppressors
Suppressor 27 T153S, L160N, S212N
Suppressor 28 T153S, L160N, S212N
Suppressor 31 Q181K, T278S
Suppressor 51 M58V, R190C
Suppressor 52 M58V, R190C
Suppressor 53 M58V, R190C
Suppressor 54 M58V, R190C
Suppressor 55 Wild-type reversion
Suppressor 57 M58V, R190C
Suppressor 58 K28N, I305L, E311V, I315L
Suppressor 59 K28N, I305L, E311V
Suppressor 60 K28N, E311V
Suppressor 61 K21Q, K28N, R308K, E311V
Suppressor 62 Wild-type reversion
Suppressor 63 R190C, R194H, K292Q, I303V
doi:10.1371/journal.pone.0004746.t001
Table 2. Suppressor mutations identified from the prkaca-
F327A background.
Suppressor Changes in Suppressors
Suppressor 1 Y229S
Suppressor 3 G186C
Suppressor 4 T51P
Suppressor 5 F327S, L173V
Suppressor 7 E17R
Suppressor 12 M120T, L40S
Suppressor 14 K285P
Suppressor 32 V310A
Suppressor 38 H62L, Q149H
Suppressor 39 T37K, D75Q, Q149H, K189N, R190H, V226A, Q242H
Suppressor 40 Q35L, A38T, E140Y, Q149H, E170D, G178V, I180L, R190H,
C199S, G214K
Suppressor 41 K28E, L40S, R93S
Suppressor 42 Q35L, K295E, I305L
Suppressor 43 L40S, K189T, T299P, Q307H, F318I
Suppressor 44 L40S, K47T, Y164H
Suppressor 46 L40S, K63N, L95M
Suppressor 47 M71I, V251I, F257I
Suppressor 48 L40S, R308K, I315L
Suppressor 49 V251F
Suppressor 66 F108I, Y215C
Suppressor 67 L40S, L157M
Suppressor 68 L40P
Suppressor 69 L40S
Suppressor 70 T37I, L40P, G282A
doi:10.1371/journal.pone.0004746.t002
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indicating that overcoming a momentous deficiency stemming
from loss of a key catalytic residue within the kinase core required
multiple changes throughout the kinase.
In contrast to suppressors identified from the prkaca-L173A
background, it is interesting to note that many of the acquired
mutations from the prkaca-F327A background are at sites that are
solvent-exposed. It is possible that these mutations affect substrate
or other protein-protein interactions, leading to enhanced or
altered affinities for inhibitor interactions or protein complex
formation to ultimately suppress the original prkaca-F327A
mutation. Additionally, multiple prkaca-F327A suppressors ac-
quired a proline mutation. Proline inherently decreases localized
mobility, thereby inhibiting conformational malleability. In this
instance, buried Pro mutations may disallow conformational
changes to impact allosteric regulation for catalysis, but surface
Pro mutations may alter interactions involving substrate binding
or protein-protein interactions.
A noteworthy example of a proline suppressor mutation was
identified in the F327A/K285P suppressor. Further structural and
biochemical characterization was performed on this suppressor to
elucidate the mechanism of suppression [17]. It was found that
Figure 4. Suppressors identified from the prkaca-L173A background. A, The original L173A mutation is highlighted yellow and the suppressor
mutations are shown in blue. PKA features are highlighted as follows: small lobe, gray; large lobe, sand; C-terminal tail,red; PKI: magenta. Some
frequently isolated suppressor mutations are labeled. Mutations are shown using PDB file 1ATP and modeled using PyMol. B, Multiple mutations
isolated from the same suppressor are connected by a dashed line and generally aligned with secondary structural elements of PKA. Secondary
structural elements are represented where alpha-helices are red and beta-sheets are blue.
doi:10.1371/journal.pone.0004746.g004
Figure 5. Suppressor mutations from the prkaca-F327A background. A, Highlighted suppressor mutations identified from the prkaca-F327A
background. The original F327A mutation is highlighted in yellow, and suppressor mutations are shown in blue. PKA features are highlighted as
follows: small lobe, gray; large lobe, sand; C-terminal tail,red; PKI: magenta. Some frequently highlighted mutations are labeled. The image was made
using PDB file 1ATP and modeled using PyMol. B, Mutations isolated from the same suppressor are connected by a dashed line. Single suppressor
mutations are listed above the corresponding secondary structural elements of PKA. Secondary structural elements are represented where alpha-
helices are red and beta-sheets are blue.
doi:10.1371/journal.pone.0004746.g005
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essential role in regulating kinase activity by participating in ATP
binding, coordinating the positioning of the Glycine-rich Loop for
catalysis and by stabilizing the linker joining the two lobes of the
kinase core. Thus, the F327A mutation caused a loss of catalytic
function by distorting the abovementioned elements. However,
biochemical studies revealed that the double mutant remained
catalytically defective, yet kinase function was restored in vivo.
Suppression was achieved by reducing the inhibitory interactions
with either the RII-subunits or the yeast homolog Bcy1p. Even
though the mutations are distal to one another, crystallographic
studies revealed that K285 provides a key contact point for
interactions with the regulatory subunits. The side chain of
Lys285, located in the aH-aI Loop of the large lobe, is typically
solvent exposed and often disordered in crystal structures where
the C-subunit is not bound to a regulatory subunit. Therefore, its
functional importance was not previously appreciated. The
suppressor mutation prevented the regulatory subunit from
binding to the kinase domain, thereby allowing the kinase to
remain constitutively active. Further, the single mutants K285P or
F327A had a modest effect on inhibition by RIIa, however, a
synergistic negative effect was observed for the double mutant.
This suggests an allosteric connection of the aH-aI Loop to the
active site. Detailed analysis of this suppressor provides an example
of how distal sites of PKA are functionally integrated in order to
regulate PKA activity.
Functional differences between PKA and Tpk2
In this study, several key residues within the nucleotide-binding
site of PKA were tested in vivo for their necessity in kinase function
in an S. cerevisiae strain devoid of native PKA expression. Despite
site conservation among the kinase superfamily, only two sites,
L173 and F327, demonstrated a loss of viability when mutated to
Ala. The biological consequences of these mutations were
previously tested in vivo using the PKA homolog Tpk2 [18].
Interestingly, although viability was lost in the tpk2-T183V mutant,
absolutely no effects were seen for the same mutant in PKA.
Likewise, prkaca-L173A and prkaca-F327A caused loss of viability in
the tpk null strain, but no consequences were evident for the
corresponding Tpk2 mutants. This demonstrates that although the
nucleotide binding pocket is conserved among the kinase
superfamily, their functional roles may not be conserved.
Some identical suppressor mutations were identified from
screening against both of the prkaca backgrounds as well as the
yeast homolog tpk2-T183V [18]. One example of this is the
acquisition of mutations at site R190. This residue lies within the
conserved kinase core and forms a socket with R93 at the end of
the C-helix. This socket interacts with W30 and F26 of the A-helix
to anchor and position the C-helix for catalytic activity. This
socket also provides support to the A-helix to maintain
conformational rigidity between the large and small lobes.
Identification of acquired mutations at R190 from two distinct
genetic backgrounds of PKA as well as the yeast homolog Tpk2
underscores the significance of the interactions between the A- and
C-helices on kinase function.
There is a clear link between cancer progression and a variety of
conserved, somatic mutations that accumulate over time in
kinases. A recent study analyzing multiple cancer data sets has
identified four residues within the catalytic core of multiple kinases
that play a dominant role in tumor progression [19]. In PKA,
these positions are L49, R190, M120 and G126. Our genetic
screening against three unique backgrounds using two PKA
homologs yielded acquisition of suppressor mutations at positions
R190 and M120 for several suppressors. This not only validates
the genetic screen as a method for identifying residues that
modulate catalytic activity, but also reconfirms the significance of
these residues in drug resistance and cancer.
Genetic screening as a tool for studying kinase regulation
Although crystal structures have shed tremendous light on
catalytic components of kinases, the more subtle regulatory
interactions distributed throughout the kinase have been difficult
to distinguish. These results suggest that viability-based genetic
screening can identify suppressors that indirectly reverse the
functional defectiveness derived from the original mutation by
compensatory effects distributed throughout the kinase. Due to the
significance of kinases in a variety of diseases, understanding
kinase regulation is critical. This method provides a platform for in
vivo identification of previously unsuspected sites that significantly
impact PKA regulation. The genetic screen presented in this study
may act as a tool to broaden our understanding of kinase
regulation and can be applied to study kinase misregulation in
disease states.
Materials and Methods
Strains and Media
The yeast strain used in this study was derived from the
Saccharomyces Genome Deletion Project [20]. The strain, LPY
06292 has the following genotype: MATa his3-1 leu2-0 lys2-0
met15-0 ura3-0 tpk1D::KANMX tpk2D::KANMX tpk3D::KANMX.T o
survive, it carries a CEN, URA3-marked plasmid bearing wild-type
TPK1 (pLP2024). Where indicated, wild-type and PKA mutants
were co-expressed in a CEN, LEU2-marked vector [21]. Growth
was at 30uC unless otherwise specified and standard techniques for
yeast manipulation were performed [15]. Cultures were grown in
either yeast extract/ peptone/ dextrose medium (YPD), Leu- Ura-
drop-out medium, or Leu- 5-FOA medium as indicated that was
prepared as described [22].
Generation of PKA pocket mutations and screening for
restored PKA function
Point mutations were introduced into sequences encoding the
nucleotide-binding pocket of Mus musculus PKA-Ca (Gene symbol:
Prkaca) using the QuikChange Site-Directed Mutagenesis Kit
(Stratagene, La Jolla, CA) using the following forward primers and
their reverse complements, respectively:
Leu49Ala:
59-AGAATCAAGACCGCGGGCACCGGATCC,
59-GGATCCGGTGCCCGCGGTCTTGAATTCT;
Val57Ala:
59-TCCTTTGGCCGAGCGATGCTGGTGAAG,
59-CTTCACCAGCATCGCTCGGCCAAAGGA;
Val104Ala:
59-TTCCCGTTCCTGGCCAAACTTGAATTC,
59-GAATTCAAGTTTGGCCAGGAACGGGAA;
Met120Ala:
59-CTGTACATGGTGGCCGAGTATGTAGCT,
59-AGCTATATACTCGGCCACCATGTACAG;
Tyr122Ala:
59-ATGGTCATCGAGGCTGTGGCCGGTGGC,
59-GCCACCGGCCACAGCCTCCATGACCAT;
Leu173Ala:
59-CCCGAGAATCTTGCGATCGACCAGCAG,
Non-Catalytic Residues of PKA
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Thr183Ala:
59-TATATTCAGGTGGCCGACTTCGGTTTT,
59-AAAACCGAAGTCGGCCACCTGAATATA;
Phe327Ala:
59-GACACTAGTAACGCTGACGACTATGAG,
59-CTCATAGTCGTCAGCGTTACTAGTGTC
Intragenic suppressor libraries of either the prkaca-L173 or
prkaca-F327A mutants were generated as previously described [18].
Coding sequence templates of prkaca bearing the mutations
encoding either L173A or F327A were used as target templates
for PCR amplification in pRS315 plasmids bearing 2000 bp
upstream and 1000 bp downstream flanking sequences from the
closest PKA-Ca homolog in S. cerevisiae, TPK1.
Phenotypic analysis of strains with point mutations in
PKA
Cultures were grown in Leu- Ura- medium. Cell densities were
normalized to OD600=1.0 and were 5-fold serially diluted in
sterilized water. Dilutions were plated onto selective medium and
grown at the indicated temperatures for 6 days.
Protein expression, immunodetection, purification of
FLAG-labeled PKA catalytic subunit, and catalytic kinase
activity assays
Immunodetection, protein purification, and catalytic activity
assays were performed as previously described [18].
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